Vascular cholesterol inhibitors and use thereof
The present invention relates to compounds having pharmacological activity in the treatment of vascular cholesterol accumulation, plasma low-density lipoproteins (LDL) abnormal aggregation and/or inhibition or reduction of the formation of VSMC foam ...
Prades, Roger +3 more
core
Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial. [PDF]
Geba GP +14 more
europepmc +1 more source
Determinants of false-positive plasma free metanephrines and methoxytyramine: the role of medications and chronic disease. [PDF]
Knigge LM +9 more
europepmc +1 more source
Reversibly reduced lipoprotein lipase in APOA5 c.553G>T-related hypertriglyceridemia successfully treated with pemafibrate. [PDF]
Miyauchi S +12 more
europepmc +1 more source
Case Report: Clinical and genetic analysis of a family with hereditary spherocytosis combined with familial chylomicronemia syndrome. [PDF]
Qin Y +10 more
europepmc +1 more source
Interesting neuroimaging findings in a child with hyperlipidemia: a case report. [PDF]
Torabi A +5 more
europepmc +1 more source
Patterns of lipid profile and genetic variations in South Asians. [PDF]
Rahmanian M.
europepmc +1 more source
<i>HSD17B4</i>-Related Disorder: Defining the Phenotype in Adult-Onset Patients. [PDF]
Falcone GMI +6 more
europepmc +1 more source
Type I Thanatophoric Dysplasia: Clinical Outcome in the Absence of Molecular Genetic Confirmation: A Case Report. [PDF]
Mesbah K +4 more
europepmc +1 more source
Delirium in critically ill COVID-19 patients: incidence, predictors, and outcomes in invasive mechanical ventilation with versus without ECMO support. [PDF]
Seeger S +8 more
europepmc +1 more source

